` MOVE (Movano Inc) vs S&P 500 Comparison - Alpha Spread

MOVE
vs
S&P 500

Over the past 12 months, MOVE has underperformed S&P 500, delivering a return of -50% compared to the S&P 500's 24% growth.

Stocks Performance
MOVE vs S&P 500

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
MOVE vs S&P 500

Loading
MOVE
S&P 500
Difference

Performance By Year
MOVE vs S&P 500

Loading
MOVE
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Movano Inc vs Peers

S&P 500
MOVE
AAPL
005930
1810
DELL
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Movano Inc
Glance View

Market Cap
38.8m USD
Industry
Technology

Movano, Inc. is a health-focused technology company. The company is headquartered in Pleasanton, California and currently employs 27 full-time employees. The company went IPO on 2021-03-23. The Company’s platform uses Radio Frequency (RF) technology, which enables the creation of scalable sensors that are small enough to fit into wearable devices and other small form factors. The Company’s platform is the foundation for its development of its product, Movano Ring. Its Movano Ring measures heart rate, heart rate variability (HRV), sleep, respiration, temperature, blood oxygen saturation (SpO2), steps, calories and incorporates women-centric features and design. The smart ring and its accompanying application seek to combine health metrics with personalized intelligent feedback and is designed for women of all ages. Its device insights help users make manageable lifestyle changes and take a more proactive approach to their health that could help mitigate the risks associated with chronic disease.

MOVE Intrinsic Value
0.42 USD
Overvaluation 93%
Intrinsic Value
Price
Back to Top